Analyst Upgrades – Gilead Sciences (NASDAQ:GILD) Stock Gets Upgraded By Citigroup from Neutral to Buy

ME Staff
-
0

Analyst Ratings For Gilead Sciences (NASDAQ:GILD)

Today, Gilead Sciences (NASDAQ:GILD) stock received an upgrade by Citigroup from Neutral to Buy with a price target of $76.00.

Some recent analyst ratings include

  • 1/30/2018-Citigroup Upgrade from a “Neutral ” rating to a ” Buy” rating.
  • 1/26/2018-Jefferies Group Upgrade from a “Hold ” rating to a ” Buy” rating.
  • 1/16/2018-Wells Fargo & Co Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
  • 1/3/2018-BMO Capital Markets Reiterated Rating of Hold.
  • 12/21/2017-Oppenheimer Reiterated Rating of Hold.

Dividend information for Gilead Sciences (NASDAQ:GILD)

Gilead Sciences (NASDAQ:GILD) pays an annual dividend of $2.08 with a yield of 2.39%.

Dividend History for Gilead Sciences (NASDAQ:GILD)

  • On 10/26/2017 Gilead Sciences announced a quarterly dividend of $0.52 2.7% with an ex dividend date of 12/14/2017 which will be payable on 12/28/2017.
  • On 7/26/2017 Gilead Sciences announced a quarterly dividend of $0.52 2.78% with an ex dividend date of 9/14/2017 which will be payable on 9/28/2017.
  • On 5/2/2017 Gilead Sciences announced a quarterly dividend of $0.52 3.09% with an ex dividend date of 6/14/2017 which will be payable on 6/29/2017.
  • On 2/7/2017 Gilead Sciences announced a quarterly dividend of $0.52 3.11% with an ex dividend date of 3/14/2017 which will be payable on 3/30/2017.
  • On 11/1/2016 Gilead Sciences announced a quarterly dividend of $0.47 2.59% with an ex dividend date of 12/13/2016 which will be payable on 12/29/2016.
  • On 7/25/2016 Gilead Sciences announced a quarterly dividend of $0.47 2.32% with an ex dividend date of 9/14/2016 which will be payable on 9/29/2016.
  • On 4/28/2016 Gilead Sciences announced a quarterly dividend of $0.47 2.13% with an ex dividend date of 6/14/2016 which will be payable on 6/29/2016.

Recent Insider Trading Activity For Gilead Sciences (NASDAQ:GILD)
Gilead Sciences (NASDAQ:GILD) has insider ownership of 1.30% and institutional ownership of 76.11%.

  • On 1/16/2018 James R Meyers, EVP, sold 100,000 with an average share price of $80.24 per share and the total transaction amounting to $8,024,000.00.
  • On 1/11/2018 Gregg H Alton, EVP, sold 30,000 with an average share price of $79.00 per share and the total transaction amounting to $2,370,000.00.
  • On 1/2/2018 Gregg H Alton, EVP, sold 15,000 with an average share price of $73.87 per share and the total transaction amounting to $1,108,050.00.
  • On 1/2/2018 John C Martin, Insider, sold 50,000 with an average share price of $73.62 per share and the total transaction amounting to $3,681,000.00.
  • On 12/1/2017 Gregg H Alton, EVP, sold 15,000 with an average share price of $74.64 per share and the total transaction amounting to $1,119,600.00.
  • On 12/1/2017 John C Martin, Insider, sold 73,333 with an average share price of $74.98 per share and the total transaction amounting to $5,498,508.34.
  • On 11/13/2017 John F Milligan, Insider, sold 220,000 with an average share price of $72.88 per share and the total transaction amounting to $16,033,600.00.

Recent Trading Activity for Gilead Sciences (NASDAQ:GILD)
Shares of Gilead Sciences closed the previous trading session at with 88.0199966430664 shares trading hands.